Beattie DT, Armstrong SR, Shaw JP et al. (2008) The in vivo gastrointestinal activity of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activity. Naunyn-Schmiedeberg’s Archives of Pharmacology 378(1), 139–147

Di Girolamo N, Maranville RE, Pathak D, Womble W, Hanzlicek A, Sypniewski L and Brandão J (2025) The 4 prokinetic drugs metoclopramide, cisapride, pyridostigmine, and capromorelin do not increase fecal output or food intake in healthy New Zealand rabbits (Oryctolagus cuniculus). Journal of the American Veterinary Medical Association 1, 1–7

Feldman ER, Singh B, Mishkin NG, Lachenauer ER, Martin-Flores M and Daugherity EK (2021) Effects of cisapride, buprenorphine, and their combination on gastrointestinal transit in New Zealand white rabbits. Journal of the American Association for Laboratory Animal Science 60(2), 221–228

Mans C, Fink DM and Ciarrocchi C (2021) Effects of oral cisapride administration in chinchillas (Chinchilla lanigera) with experimentally induced fecal output reduction. Journal of Exotic Pet Medicine 38, 21–25

Tsubouchi T, Saito T, Mizutani F, Yamauchi T and Iwanaga Y (2003) Stimulatory action of itopride hydrochloride on colonic motor activity in vitro and in vivo. The Journal of Pharmacology and Experimental Therapeutics 306(2), 787–793

Yogo K, Onoma M, Ozaki K et al. (2008) Effects of oral mitemcinal (GM-611), erythromycin, EM-574 and cisapride on gastric emptying in conscious rhesus monkeys. Digestive Diseases and Sciences 53(4), 912–91